Faculdades Pequeno Príncipe, Research Institute Pelé Pequeno Príncipe, Curitiba, PR, Brazil.
Universidade Alto Vale do Rio do Peixe (UNIARP), Caçador, SC, Brazil.
J Mol Med (Berl). 2024 Sep;102(9):1089-1100. doi: 10.1007/s00109-024-02467-z. Epub 2024 Jul 23.
MiRNAs, a class of non-coding RNA molecules, have emerged as critical modulators of telomere length and telomerase activity by finely tuning the expression of target genes (and not gene targets) within signaling pathways involved in telomere homeostasis. The primary objective of this systematic review was to compile and synthesize the existing body of knowledge on the role, association, and involvement of miRNAs in telomere length. Additionally, the review explored the regulation, function, and activation mechanism of the human telomerase reverse transcriptase (hTERT) gene and telomerase activity in tumor cells. A comprehensive analysis of 47 selected articles revealed 40 distinct miRNAs involved in these processes. These miRNAs were shown to exert their function, in both clinical cases and cell line models, either directly or indirectly, regulating hTERT and telomerase activity through distinct molecular mechanisms. The regulatory roles of these miRNAs significantly affected major cancer phenotypes, with outcomes largely dependent on the tissue type and the cellular actions within the tumor cells, whereby they functioned as oncogenes or tumor suppressors. These findings strongly support the pivotal role of miRNAs in modulating telomere length and telomerase activity, thereby contributing to the intricate and complex regulation of telomere homeostasis in tumor cells. Moreover, they emphasize the potential of targeting miRNAs and key regulatory genes as therapeutic strategies to disrupt cancer cell growth and promote senescence, offering promising avenues for novel cancer treatments.
miRNAs 是一类非编码 RNA 分子,通过精细调节参与端粒稳态的信号通路中靶基因(而非基因靶标)的表达,成为端粒长度和端粒酶活性的关键调节因子。本系统综述的主要目的是汇集和综合 miRNA 在端粒长度中的作用、关联和参与的现有知识。此外,该综述还探讨了人类端粒酶逆转录酶 (hTERT) 基因和肿瘤细胞中端粒酶活性的调节、功能和激活机制。对 47 篇选定文章的综合分析揭示了 40 种不同的 miRNA 参与了这些过程。这些 miRNA 无论是在临床病例还是细胞系模型中,都通过不同的分子机制直接或间接地发挥作用,调节 hTERT 和端粒酶活性。这些 miRNA 的调节作用显著影响主要的癌症表型,其结果在很大程度上取决于组织类型和肿瘤细胞内的细胞作用,从而发挥癌基因或肿瘤抑制基因的作用。这些发现有力地支持了 miRNA 在调节端粒长度和端粒酶活性中的关键作用,从而有助于肿瘤细胞中端粒稳态的复杂和精细调节。此外,它们强调了靶向 miRNA 和关键调节基因作为治疗策略的潜力,以破坏癌细胞生长并促进衰老,为新型癌症治疗提供了有希望的途径。